Equity Capital And Reserves Alterar Data
AbbVie USD 12.09B 772M 2023-09
Aceragen USD 22.55M 16.39M 2023-03
Adma Biologics USD 135.21M 16.23M 2023-12
Amgen USD 6.23B 1.42B 2023-12
AstraZeneca USD 37.2B 195M 2023-09
Biogen USD 14.8B 315.6M 2023-12
BioMarin Pharmaceutical USD 4.95B 54.65M 2023-12
Bristol-Myers Squibb USD 29B 2.98B 2023-09
Dynavax Technologies USD 622.07M 17.16M 2023-12
Gilead Sciences USD 22.75B 435M 2023-12
Merck USD 41.25B 2.55B 2023-09
Minerva Neurosciences USD -20046000 7.53M 2023-09
Nektar Therapeutics USD 159.37M 37.59M 2023-09
Neurocrine Biosciences USD 2B 149.1M 2023-09
Pfizer USD 96.93B 2.08B 2023-09
Regeneron Pharmaceuticals USD 25.97B 1.07B 2023-12
Roche Holding CHF 26.52B 1.48B 2023-06
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
TG Therapeutics USD 160.5M 4.27M 2023-12
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09



Dynavax Technologies Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.